Latest / Pharmacy Podcast Network / Moving Beyond a Check-the-Box Model: Talking Specialty Pharmacy Accreditation with ACHC| NASP Specialty Pharmacy Podcast

Transcript

Moving Beyond a Check-the-Box Model: Talking Specialty Pharmacy Accreditation with ACHC| NASP Specialty Pharmacy Podcast · Pharmacy Podcast Network

• 0:05
  Speaker 1: You are listening to the global network of podcasters dedicated
• 0:09
  Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
• 0:26
  Speaker 2: You're listening to the NASP Specialty Pharmacy Podcast, a collaboration
• 0:31
  Speaker 2: between the National Association of Specialty Pharmacy and the Pharmacy
• 0:35
  Speaker 2: Podcast Network. Each episode dives deep into trends, challenges, innovations,
• 0:40
  Speaker 2: and patient centric practices shaping the future of this dynamic
• 0:44
  Speaker 2: and rapidly evolving industry. Whether you're a pharmacist or healthcare provider,
• 0:49
  Speaker 2: patient advocate, or industry leader, you'll hear expert insights, real
• 0:53
  Speaker 2: world evidence, and thought provoking discussion that highlights all that
• 0:57
  Speaker 2: makes specialty pharmacy special.
• 1:00
  Speaker 3: In support of NASP's mission to empower specialty pharmacy stakeholders
• 1:04
  Speaker 3: to advance the standard of patient care, NASP supports a
• 1:08
  Speaker 3: free market healthcare system in which all specialty pharmacies compete
• 1:11
  Speaker 3: on the same fare and level playing field, because that
• 1:14
  Speaker 3: is in the best interest of the patients.
• 1:16
  Speaker 4: We collectively serve.
• 1:17
  Speaker 3: NASP is committed to working with all stakeholders and policymakers
• 1:21
  Speaker 3: to ensure that all patients have access to the life
• 1:24
  Speaker 3: saving medications they need and the high touch patient care
• 1:26
  Speaker 3: and support services they deserve from the pharmacy of their choosing.
• 1:30
  Speaker 4: Hello, my name Isshila Arquette, and I am the President
• 1:33
  Speaker 4: and CEO of the National Association of Specialty Pharmacy. I
• 1:36
  Speaker 4: am delighted to welcome my special guest, doctor Caroline Jirodau,
• 1:40
  Speaker 4: to this episode of the NSP podcast. Doctor Girdeau farm
• 1:45
  Speaker 4: d MBA, PMP, BCPs and ACCHC Pharmacy Program directors over
• 1:52
  Speaker 4: thirty years a pharmacy practice in strategic leadership experience. Doctor
• 1:57
  Speaker 4: G's diverse expertise in clinical knowledge will for their ACH's
• 2:01
  Speaker 4: mission to deliver exceptional service and pharmacy accreditation. Doctor g
• 2:05
  Speaker 4: graduated from the University of North Carolina at Chapel Hill
• 2:08
  Speaker 4: School of Pharmacy and earned her Master of Business Administration
• 2:13
  Speaker 4: from UNC Keenan Flagler School of Business. She completed her
• 2:17
  Speaker 4: pharmacy practice residency at UNC Healthcare and Chapel Hill and
• 2:22
  Speaker 4: her Critical Care Specialty residency at Virginia Commonwealth University Medical
• 2:26
  Speaker 4: College of Virginia and Richmond. In addition to holding a
• 2:30
  Speaker 4: doctorate in pharmacy, doctor G has certifications from the Board
• 2:34
  Speaker 4: of Pharmaceutical Specialties as a pharmacotherapy specialist and from the
• 2:39
  Speaker 4: Project Management Institute as a project management professional. During her
• 2:43
  Speaker 4: long career, doctor g has held leadership roles at premier
• 2:46
  Speaker 4: healthcare institutions, including pharmacy management and clinical coordination positions at
• 2:52
  Speaker 4: UNC rex Healthcare, specialty roles at UNC Chapel Hill Medical
• 2:57
  Speaker 4: Center and WakeMed Health and Hospital, and clinical research positions
• 3:02
  Speaker 4: with leading clinical research organizations. She really resides in North
• 3:06
  Speaker 4: Carolina with her husband, David and their two children. In
• 3:09
  Speaker 4: her free time, she enjoys being outdoors, exercising and tending
• 3:12
  Speaker 4: to her garden. Caroline, thanks so much for joining me today.
• 3:17
  Speaker 5: Thank you, Sheila. I'm delighted to be here.
• 3:21
  Speaker 4: How's the garden doing? Is it a good growing season
• 3:23
  Speaker 4: or a bad growing season?
• 3:25
  Speaker 5: It is not much gardening this season. Honestly, I'm really
• 3:30
  Speaker 5: focused on all things achc as I adopt my new
• 3:35
  Speaker 5: role here. So I've got some flowers and pods and
• 3:41
  Speaker 5: a lovely hummingbird feeder that I'm enjoying very much this summer.
• 3:45
  Speaker 4: Well, there you go, that's all you need. I live
• 3:46
  Speaker 4: in Florida, So like the growing season I think is
• 3:48
  Speaker 4: over in February, right, it just gets too darn hot.
• 3:51
  Speaker 4: So I give up literally understand, that's a lot of
• 3:55
  Speaker 4: critters in the garden, right that I really don't want
• 3:56
  Speaker 4: to come face to face with. So I'm good, all right,
• 4:01
  Speaker 4: So let's get started here. Specialty pharmacy accreditation can apply
• 4:04
  Speaker 4: across different business models. How does ACHC help organizations understand
• 4:09
  Speaker 4: which accreditation pathway would best fit their scope of services?
• 4:15
  Speaker 5: Great question, Chila. Every specialty pharmacy operates a little differently,
• 4:19
  Speaker 5: so we start by understanding the services that each one provides,
• 4:23
  Speaker 5: the patients they serve, and any manufacturer payer requirements, and
• 4:27
  Speaker 5: from there we hope to identify the accreditation pathway that
• 4:29
  Speaker 5: aligns with that particular pharmacy's operations, whether it be hospital
• 4:34
  Speaker 5: based or independently owned. And the goal is to make
• 4:38
  Speaker 5: the process straightforward and ensure organizations pursue accreditation that is
• 4:42
  Speaker 5: the best fit for their business. AHC offers two different
• 4:46
  Speaker 5: types of specialty pharmacy accreditation. Our SRX service includes the
• 4:51
  Speaker 5: CMS post P ten accreditation requirements. And for those of
• 4:56
  Speaker 5: you who don't know what dommy post stands for. That
• 4:58
  Speaker 5: stands for Adorable Medical Equipment, Prosthetic, Orthotic and Supplies and
• 5:03
  Speaker 5: so businesses who want to build Medicare for product codes
• 5:06
  Speaker 5: will want to seek the SRX accreditation service. We also
• 5:11
  Speaker 5: offer a specialty pharmacy accreditation service withoutmy posts quality and
• 5:15
  Speaker 5: supplier standards, and we call this the SRX only accreditation
• 5:20
  Speaker 5: And so businesses who only need the SRX only without
• 5:25
  Speaker 5: posts can elect to have this particular survey experience perform virtually.
• 5:30
  Speaker 5: And so this is a very popular option for our
• 5:33
  Speaker 5: customers and they have the option to do it in
• 5:37
  Speaker 5: person or virtually, and it's again something that a lot
• 5:41
  Speaker 5: of customers prefer to do virtually. I'd also like to
• 5:44
  Speaker 5: put in a good word for our customer service and
• 5:46
  Speaker 5: account advisor teams at ACCHC. They are valuable resources that
• 5:51
  Speaker 5: ensure the right accreditation is chosen based on your pharmacy's
• 5:55
  Speaker 5: business model. And new customers can seek guidance from our
• 5:58
  Speaker 5: ACHD customer service representative and existing customers can also reach
• 6:03
  Speaker 5: out to their account advisor.
• 6:07
  Speaker 4: Awesome and just like a point of clarification, so the
• 6:10
  Speaker 4: demi post benefits are those typically covered and billed as
• 6:13
  Speaker 4: medical benefits.
• 6:16
  Speaker 5: They are it's under product codes and it's fall under
• 6:20
  Speaker 5: Medicare part.
• 6:21
  Speaker 4: Be okay, okay, yes, all right, that is from my
• 6:25
  Speaker 4: health plan days. Those are typically medical benefits, okay, and
• 6:30
  Speaker 4: not all pharmacies right carry those or have the capabilities
• 6:34
  Speaker 4: to bill that benefit. So that's nice that you offer both,
• 6:39
  Speaker 4: we do.
• 6:40
  Speaker 3: So.
• 6:40
  Speaker 4: How are emerging industry trends impacting pharmacy practice and the
• 6:44
  Speaker 4: types of accreditation available?
• 6:48
  Speaker 5: Yes, so, pharmacy practice is undergoing significant transformation, driven by
• 6:52
  Speaker 5: advanced therapies that are fundamentally changing pharmacist roles. We know
• 6:56
  Speaker 5: that biologics selling gene therapies and treatments for rare disease
• 7:00
  Speaker 5: and orphan diseases are expensive, clinically complex, and require ongoing management.
• 7:07
  Speaker 5: As a result, pharmacists and pharmacies are increasingly seeking additional training,
• 7:11
  Speaker 5: credentials and third party validation with a focus on longitudinal
• 7:15
  Speaker 5: patient monitoring, adherents and outcomes. In response to the rise
• 7:19
  Speaker 5: in rare disease treatments. ADHD offers a distinction in rare
• 7:23
  Speaker 5: and vorphin disease and we currently have thirty five organizations
• 7:27
  Speaker 5: accredited with this distinction. Our standards focus on ensuring that
• 7:31
  Speaker 5: these patients receive structured longitudinal management throughout their treatment journey,
• 7:36
  Speaker 5: and this niche of specialty practice faces complex pair issues
• 7:39
  Speaker 5: extensive enrollment and assistance programs. It requires significant due diligence
• 7:44
  Speaker 5: in reporting to manufacturers. The trend in complex therapies for
• 7:49
  Speaker 5: complex disease states has also led EHD to recently launch
• 7:53
  Speaker 5: our newest Distinction in Immunoglobulin Therapy. AD collaborated with IGNS,
• 7:59
  Speaker 5: the Globular and National Society and industry partners to develop
• 8:04
  Speaker 5: the first of his kind distinction in amito Globulin Therapy.
• 8:08
  Speaker 5: IGNS is the premier organization for education, research, and advanced
• 8:12
  Speaker 5: clinician certifications in IG therapy. Their organization has what we
• 8:19
  Speaker 5: call IGNS Standards of Practice and they were incorporated into
• 8:22
  Speaker 5: the distinction's framework to demonstrate excellence. And so these certifications
• 8:27
  Speaker 5: help a team demonstrate advanced competence and practice and at
• 8:31
  Speaker 5: a higher level for IG therapy. So by offering these
• 8:35
  Speaker 5: two distinctions, ACHD aligns accreditation with emerging specialty pharmacy trends
• 8:40
  Speaker 5: and supports advanced clinical practice and gives providers a structured
• 8:43
  Speaker 5: way to demonstrate excellence in managing complex patients and their therapies. So,
• 8:49
  Speaker 5: how our recent CMS changes to DEMI post requirements impacting
• 8:53
  Speaker 5: the accreditation survey process. Thank you for your question. The
• 8:58
  Speaker 5: CM's final role of active January First twenty twenty six
• 9:02
  Speaker 5: significantly increases oversight per pharmacies billing demi posts, primarily to
• 9:07
  Speaker 5: address broad waste and abuse, where improper overpayments have been
• 9:11
  Speaker 5: roughly twenty percent in recent years. From an accreditation perspective,
• 9:16
  Speaker 5: the biggest impact is increased frequency and tighter timelines. Pharmacies
• 9:21
  Speaker 5: who build demiposts now require annual accreditation surveys with a
• 9:25
  Speaker 5: one year cycle, while pharmacy accreditation remains on a three
• 9:29
  Speaker 5: year cycle. Surveys are more focused including Medicare patient record review,
• 9:35
  Speaker 5: equipment evaluation, and compliance with quality and supplier standards. In addition,
• 9:40
  Speaker 5: corrective action time plans or what we used to call
• 9:44
  Speaker 5: a clinical plan of correction, those are under a reduced timeframe.
• 9:50
  Speaker 5: Previously at ACFC it was thirty days and now it's
• 9:53
  Speaker 5: fifteen days, and that reflects cms's expectation for faster reporting.
• 9:58
  Speaker 5: There's also more trigger that require surveys. Changes such as
• 10:03
  Speaker 5: adding a branch relocation, certain ownership changes, or introducing new
• 10:08
  Speaker 5: demi post product codes may now prompt an additional survey.
• 10:12
  Speaker 5: These all increase the demand for creditation services, and finally,
• 10:17
  Speaker 5: CMS has increased scrutiny, both for DME suppliers as well
• 10:22
  Speaker 5: as accrediting organizations such as AHC. Expirations can no longer
• 10:27
  Speaker 5: be extended, and accreditation also cannot be granted until all
• 10:31
  Speaker 5: deficiencies found on survey are resolved. Late applications also potentially
• 10:38
  Speaker 5: put out pharmacies p TAN and their ability to build
• 10:40
  Speaker 5: medicare at risk. So the key takeaway is to submit
• 10:44
  Speaker 5: renewal applications early and ensure you have a strong compliance
• 10:48
  Speaker 5: program in place, as expectations and enforcement are significantly higher
• 10:52
  Speaker 5: under this rule.
• 10:54
  Speaker 4: Specialty phantasy, as you mentioned, continues to evolve alongside growing
• 10:58
  Speaker 4: expectations from right the payers, the manufacturers, the providers, and
• 11:02
  Speaker 4: the patients. What are some of the biggest operational and
• 11:05
  Speaker 4: quality risks specialty pharmacies should be paying attention to right
• 11:09
  Speaker 4: now and how do they prepare?
• 11:12
  Speaker 5: I think the biggest risk facing specialty pharmacies right now
• 11:14
  Speaker 5: fall into two closely connected categories. One is proving the
• 11:18
  Speaker 5: quality of care and secondly, managing increased operational complexity. First,
• 11:25
  Speaker 5: specialty pharmacies need to do more than just dispense medication.
• 11:28
  Speaker 5: They really need to show that the therapy is benefiting
• 11:31
  Speaker 5: the patient, and that requires knowing what outcomes payers and
• 11:35
  Speaker 5: manufacturers expect, collecting the right data, and tracking trends over time.
• 11:41
  Speaker 5: The refill process is also another important quality risk. Pharmacies
• 11:46
  Speaker 5: should not automatically refill a medication without first confirming adherents, tolerance,
• 11:51
  Speaker 5: and continued benefit. A refill assessment should be built into
• 11:55
  Speaker 5: the workflow before dispensing. From an operational perspective, data reporting
• 12:00
  Speaker 5: remains difficult because payers and manufacturers often require different information
• 12:05
  Speaker 5: or formats. Until the industry moves towards greater standardization for
• 12:11
  Speaker 5: data transfer and communication, pharmacies need to really develop clear
• 12:15
  Speaker 5: internal processes for managing and validating those requirements, which also
• 12:21
  Speaker 5: leads to another challenge, which is vendor oversight is also
• 12:24
  Speaker 5: very critical. Pharmacies should really verify that their vendors are
• 12:29
  Speaker 5: properly licensed, qualified, secure, and are able to meet data
• 12:33
  Speaker 5: transmission requirements. Finally, insurance changes and new prior offs, for example,
• 12:40
  Speaker 5: especially at the beginning of the year, can delay therapy.
• 12:44
  Speaker 5: Pharmacies should identify high risk patients early and begin benefit
• 12:48
  Speaker 5: verification proactively and communicate with patients and prescribers before delay
• 12:53
  Speaker 5: results and anis does I work with other team members
• 12:58
  Speaker 5: at ADHD and we feel complaints both from patients and caregivers.
• 13:03
  Speaker 5: And this is a very typical theme where patients are
• 13:07
  Speaker 5: missing doses or have delays in therapy. Could some of
• 13:10
  Speaker 5: the delays have been over thirty days or longer than
• 13:13
  Speaker 5: a month, And it's really tragic when this happens. And
• 13:16
  Speaker 5: again a lot of this could have been reduced or
• 13:19
  Speaker 5: minimized had there been enough proactive involvement in communication with
• 13:24
  Speaker 5: the benefits, so you know, providing better continuity of care.
• 13:31
  Speaker 5: So ultimately the goal is to have workflows that protect
• 13:34
  Speaker 5: continuity of care and then also value really the proof
• 13:38
  Speaker 5: of the quality that is being provided.
• 13:43
  Speaker 4: Creditation is often viewed as a requirement for access or
• 13:48
  Speaker 4: reimbursement or barrier too. But how can specialty pharmacies use
• 13:52
  Speaker 4: the process as a strategic advantage.
• 13:56
  Speaker 5: Pharmacies that gain those from accreditation do not treat it
• 14:00
  Speaker 5: as an event that happens once every three years. They
• 14:02
  Speaker 5: use it as an ongoing framework for continuous improvement that
• 14:06
  Speaker 5: can strengthen operations, improve consistency across teams, reduce risk, and
• 14:11
  Speaker 5: demonstrate a clear commitment to quality. For example, when a
• 14:15
  Speaker 5: shipping error occurs, the goal should not be simply to
• 14:17
  Speaker 5: correct that one shipment. The pharmacy should take a deeper
• 14:21
  Speaker 5: dive and ask whether training, a policy, a process, technology,
• 14:25
  Speaker 5: or perhaps communication was the breakdown that contributed to the error.
• 14:30
  Speaker 5: The same approach applies to near misses. Rather than viewing
• 14:34
  Speaker 5: them as isolated events, strong orientiations will use them as
• 14:38
  Speaker 5: opportunities to improve safety before another patient is affected. When
• 14:44
  Speaker 5: approached strategically, accreditation becomes more than just a credential. It
• 14:48
  Speaker 5: becomes a competitive advantage that builds confidence with patients, referral sources, manufacturers,
• 14:54
  Speaker 5: and payers.
• 14:56
  Speaker 4: So now let's flip it a little bit. What should
• 14:58
  Speaker 4: specialty pharmacies look for when they are evaluating and selecting
• 15:02
  Speaker 4: an accrediting organization?
• 15:05
  Speaker 5: I really like this question. When evaluating an accredited organization,
• 15:09
  Speaker 5: specialty pharmacies should first make sure that the accreditor meets
• 15:12
  Speaker 5: the requirements of the payers and the manufacturers that they
• 15:15
  Speaker 5: are working with. That is the starting point, but it
• 15:19
  Speaker 5: should not be the only consideration. Pharmacy should also look
• 15:23
  Speaker 5: closely at the experience of the surveyors. Ideally, the accreditor
• 15:27
  Speaker 5: has surveyors with broad therapeutic and operational expertise who understand
• 15:32
  Speaker 5: the specialty pharmacy environment and take a collaborative approach to
• 15:35
  Speaker 5: the survey process. Education is another important factor. The right
• 15:41
  Speaker 5: accreditor should be able to provide support that goes beyond
• 15:44
  Speaker 5: explaining the standards. At ACCHC, for example, we offer education
• 15:49
  Speaker 5: on real world issues that our customers are facing that
• 15:53
  Speaker 5: includes webinars on preparing for pharmacy inspections, hands on compounding education,
• 15:58
  Speaker 5: and our new simulated clean room and guidance related to
• 16:02
  Speaker 5: recent Medicare and demi post changes. We also bring healthcare
• 16:07
  Speaker 5: professionals together through our acc Academy, where participants from pharmacy, hospital,
• 16:13
  Speaker 5: home health, and other sectors can learn from one another.
• 16:17
  Speaker 5: Our next conference is in Nashville in March of twenty
• 16:20
  Speaker 5: twenty seven. Regulatory support from your accreditor is also valuable.
• 16:26
  Speaker 5: Regulations can be complex and change quickly, so having access
• 16:31
  Speaker 5: to experts who can help interpret those requirements can also
• 16:35
  Speaker 5: make a significant difference. Ultimately, the right accreditation partner should
• 16:40
  Speaker 5: do more than evaluate an organization every few years. It
• 16:44
  Speaker 5: should provide the expertise, education, and resources to help your
• 16:48
  Speaker 5: pharmacy continuously improve and adapt to industry changes.
• 16:54
  Speaker 4: So there can be a perception in the marketplace that
• 16:57
  Speaker 4: one accreditation pathway carries more prestige another. What misconceptions do
• 17:02
  Speaker 4: you think exist about accreditation organizations and how should pharmacies
• 17:06
  Speaker 4: think about credibility, rigor and value again when making that
• 17:10
  Speaker 4: selection decision.
• 17:14
  Speaker 5: I also very much appreciate this question. One commonnessconception is
• 17:19
  Speaker 5: that all accreditation experiences are the same or that one name
• 17:23
  Speaker 5: automatically carries more value. In reality, organizations should focus on
• 17:28
  Speaker 5: whether the accreditor is recognized by the stakeholders who matter
• 17:32
  Speaker 5: to their business, and whether the standards are rigorous, relevant,
• 17:36
  Speaker 5: and designed to improve patient care. The greatest value comes
• 17:40
  Speaker 5: from an accreditation process that strengthens your organization and your team,
• 17:45
  Speaker 5: not just one that results in a certificate on the wall.
• 17:50
  Speaker 5: And I like to bring this out to to me.
• 17:53
  Speaker 5: The A in accreditation stands for accountability, and that means
• 17:57
  Speaker 5: accountability to standards. The buck stops with you as the
• 18:01
  Speaker 5: pharmacy and pharmacist. Are you holding your business accountable to
• 18:05
  Speaker 5: accreditation standards?
• 18:08
  Speaker 4: I love that patient centered care is central to specialty pharmacy.
• 18:13
  Speaker 4: So how does acchc's A protation assessment in individualized care
• 18:18
  Speaker 4: planning help pharmacies move beyond a check the box kind
• 18:21
  Speaker 4: of model.
• 18:24
  Speaker 5: Yeah, this is a challenge I think in any healthcare
• 18:28
  Speaker 5: setting these days. ADHD standards encourage pharmacies to use the
• 18:33
  Speaker 5: information to create a care plan that is specific to
• 18:35
  Speaker 5: the drug, the disease, the patient. That last element, the
• 18:40
  Speaker 5: patient is so especially important because perhaps the pharmacist goals
• 18:44
  Speaker 5: may not align or be the same as the patient's goals.
• 18:48
  Speaker 5: The pharmacist, for example, may be focused on one clinical marker,
• 18:52
  Speaker 5: while the patient may be most concerned about managing side effects,
• 18:55
  Speaker 5: returning to work, or being able to participate in activities
• 18:59
  Speaker 5: of daily life, and so ultimately the patient needs to
• 19:02
  Speaker 5: be part of that conversation. The goal is to ensure
• 19:07
  Speaker 5: the pharmacists and the patient are working toward the same outcomes.
• 19:11
  Speaker 5: When pharmacies continually reassess the patient and they update the
• 19:15
  Speaker 5: care plan and evaluate those results, the process moves beyond
• 19:19
  Speaker 5: checking a box and it becomes truly patient or personalized care.
• 19:26
  Speaker 4: Medically integrated dispensing is becoming more common as practices are
• 19:30
  Speaker 4: looking for more connected ways to manage complex therapies and
• 19:34
  Speaker 4: complex patients. How can accreditation support medically integrated dispensing programs,
• 19:40
  Speaker 4: particularly in areas like oncology and immunoglobular therapy traditionally specialty
• 19:46
  Speaker 4: pharmacy areas.
• 19:48
  Speaker 5: Thank you for this question. So, Medically integrated dispensaries or
• 19:53
  Speaker 5: dispensing programs are designed to bring medication access closer to
• 19:58
  Speaker 5: the patient's care team, which can be especially valuable in
• 20:01
  Speaker 5: complex areas such as tencology or inmo globulent therapy. Medically
• 20:06
  Speaker 5: integrated dispensaries or I like to abbreviate it MIDS, those
• 20:10
  Speaker 5: are usually again located in a provider's office or clinic.
• 20:15
  Speaker 5: And because mids operate different from a traditional pharmacy and
• 20:19
  Speaker 5: they may not have a pharmacist directs involvement. For this reason,
• 20:24
  Speaker 5: I almost feel like accreditation and the keys for accreditation
• 20:27
  Speaker 5: becomes stronger because those types of practice setting practice settings
• 20:33
  Speaker 5: need strong framework for medication management, compliance and quality oversight.
• 20:39
  Speaker 5: And so I'll just say too for AHD, the types
• 20:42
  Speaker 5: of accreditation that we offer and MID is again typically
• 20:46
  Speaker 5: the SERX only Especialty Pharmacy Accreditation without DEMI post codes.
• 20:52
  Speaker 5: That's the accreditation that we typically offer to this type
• 20:55
  Speaker 5: of practice setting. Accreditation establishes again expectations for policies, documentation,
• 21:02
  Speaker 5: patient education, care coordination, follow up and continuous quality improvement.
• 21:08
  Speaker 5: A lot of the mds that I have been familiar
• 21:12
  Speaker 5: with employ a pharmacy technician, and so oftentimes those pharmacy
• 21:17
  Speaker 5: technicians have always worked with a pharmacist. So the fact
• 21:20
  Speaker 5: that they don't have one readily available to them leaves
• 21:25
  Speaker 5: them with performance gaps and how to operate independently without
• 21:32
  Speaker 5: a direct pharmacist oversight, and so the accreditation framework helps
• 21:36
  Speaker 5: to really set them up for success. It also helps
• 21:40
  Speaker 5: to make sure that communication between providers, pharmacists, and other
• 21:43
  Speaker 5: members of the care team is consistent and well defined.
• 21:48
  Speaker 5: From a business perspective, accreditation can also help to support
• 21:52
  Speaker 5: payer and PBM networks, strengthen opportunities to access specialty or
• 21:57
  Speaker 5: limited drug distribution networks signals Again, the A and accreditation
• 22:02
  Speaker 5: for accountability to manufacturers and other partners. So in closing,
• 22:08
  Speaker 5: accreditation really helps medically integrated dispensing programs operate with consistent processes,
• 22:14
  Speaker 5: appropriate oversight, and a clear commitment to safety, quality and
• 22:18
  Speaker 5: patient centered care that creates a more coordinated and see
• 22:21
  Speaker 5: what's experience for patients receiving complex therapies directly from prescribers.
• 22:28
  Speaker 4: Thank you so much, Caroline for chatting with me today
• 22:31
  Speaker 4: and for sharing this valuable information.
• 22:34
  Speaker 5: Thank you, Sheila, It's been a real pleasure. I love
• 22:38
  Speaker 5: being a part of NASS and really I think your
• 22:43
  Speaker 5: mission for MAASPS and Achd's mission are very well aligned
• 22:48
  Speaker 5: and I appreciate this opportunity to talk more about our
• 22:50
  Speaker 5: services today.
• 22:52
  Speaker 4: Thank you. We appreciate all of your support. As a reminder,
• 22:56
  Speaker 4: ANYSP corporate members are invited to be my guest and
• 22:58
  Speaker 4: one complimentary pot ut per year. For more information about
• 23:02
  Speaker 4: this or other na SP membership benefits and events, please
• 23:05
  Speaker 4: feel free to reach out to membership at n A
• 23:08
  Speaker 4: s p n e t dot org or visit our
• 23:12
  Speaker 4: website at www dot n A s P n e
• 23:16
  Speaker 4: t dot org. Until next time, have a great day.